Location History:
- Ann Arbor, MI (US) (2016)
- Frederick, MD (US) (2016)
Company Filing History:
2 out of 3,381 
1 out of 580 
Years Active: 2016
Title: Fardokht Abulwerdi: Innovator in Medicinal Chemistry
Introduction
Fardokht Abulwerdi is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of small molecule inhibitors for therapeutic applications.
Latest Patents
Fardokht holds 2 patents that focus on innovative approaches to cancer treatment. His latest patents include "Small molecule inhibitors of Mcl-1 and the uses thereof," which introduces a new class of small molecules with a sulfonamido-1-hydroxynaphthalene structure. These molecules function as inhibitors of the Mcl-1 protein, offering potential therapeutic benefits for cancer and other diseases. Another patent, "Small molecule inhibitors of MCL-1 and uses thereof," features a pyrazolopyridine structure, further expanding the possibilities for Mcl-1 inhibition in medicinal applications.
Career Highlights
Fardokht has worked with prestigious institutions such as the University of Michigan and Wayne State University. His research has focused on developing innovative solutions to combat cancer through targeted molecular therapies.
Collaborations
Fardokht has collaborated with esteemed colleagues, including Zaneta Nikolovska-Coleska and Hollis Showalter. These partnerships have enhanced his research efforts and contributed to the advancement of medicinal chemistry.
Conclusion
Fardokht Abulwerdi's work in developing small molecule inhibitors represents a significant advancement in cancer therapeutics. His innovative patents and collaborations highlight his commitment to improving medical treatments and outcomes.